Isentress (raltegravir) / Merck (MSD) 
Welcome,         Profile    Billing    Logout  

7 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Isentress (raltegravir) / Merck (MSD)
2014-004578-40: SSAT 066 Renal Integrase Study

Not yet recruiting
4
60
Europe
Tivicay 50 mg film - coated tablets, Isentress 400 mg Film-coated Tablets, Truvada 200 mg/245 mg film-coated tablets, Stribild 150 mg/150 mg/200 mg/245 mg film-coated tablets, Film-coated tablet, Tivicay 50 mg film-coated tablets, Isentress 400 mg Film-coated Tablets, Truvada 200 mg/245 mg film-coated tablets, Stribild 150 mg/150 mg/200 mg/245 mg film-coated tablets
St Stephen's AIDS Trust, Merck, Sharp & Dohme Limited
HIV
 
 
2016-000437-43: The time to protection and adherence requirements of Raltegravir with or without lamivudine in protection from HIV infection

Not yet recruiting
4
36
Europe
Raltegravir, Lamivudine, Tablet, Film-coated tablet, Raltegravir, Lamivudine
Guy's and St Thomas NHS Foundation Trust, Merck Sharp & Dhome Ltd
HIV, HIV, Diseases [C] - Virus Diseases [C02]
 
 
2017-004750-42: EFFICACY AND SAFETY OF A SIMPLIFICATION TREATMENT BASED ON DOLUTEGRAVIR AND DARUNAVIR / COBICISTAT VS USUAL TREATMENT IN SUPPRESSED HIV-1-INFECTED PATIENTS WITH MULTIDRUG RESISTANCE. Eficacia y seguridad de Dolutegravir más Darunavir/cobicistat como tratamiento de simplificación frente al tratamiento habitual en pacientes infectados por el VIH-1 virológicamente suprimidos y con resistencia a múltiples fármacos.

Ongoing
4
100
Europe
lamivudine, Efavirenz, Nevirapine, Film-coated tablet, Coated tablet, Capsule, hard, Tablet, Rezolsta, Tivicay, Ziagen, EMTRIVA, VIREAD, kivexa, Truvada, Intelence, Edurant, Atripla, Eviplera, Reyataz, Prezista, Kaletra, Norvir, Evotaz, Isentress, Stribild, Triumeq, Genvoya, Celsentri, Descovy
FUNDACIÓ LLUITA CONTRA LA SIDA, ViiV Healthcare
HIV-1 VIH-1, HIV infection Infección por VIH, Diseases [C] - Virus Diseases [C02]
 
 
PANNA-B PK, NCT05648201: Study on PhArmacokinetics of First liNe Antiretrovirals in Healthy Breastfeeding Volunteers

Recruiting
4
36
Europe
Doravirine 100Mg Tab, pifeltro, Raltegravir 600Mg Tab, issentres, Biktarvy 50/200/25 Tab, biktarvy
Radboud University Medical Center, ZonMw: The Netherlands Organisation for Health Research and Development, Merck Sharp & Dohme LLC
Hiv
11/24
12/24
2019-004195-19: A randomized comparative phase II trial evaluating the capacity of the dual combination doravirine/raltegravir to maintain virological success in HIV-1 infected patients with an HIV-RNA plasma viremia below 50 copies/mL under a current antiretroviral regimen

Not yet recruiting
2
150
Europe
Isentress, Pifeltro, J05AX08, J05AR24, Tablet, ISENTRESS, Pifeltro
Centre de Recherche et d’Etudes sur la Pathologie Tropicale et le Sida (CREPATS), Centre de Recherche et d’Etudes sur la Pathologie Tropical et le Sida (CREPATS), CREPATS, Centre de Recherche et d’Etudes sur la Pathologie Tropical et le Sida (CREPATS)
HIV disease, HIV disease, Diseases [C] - Virus Diseases [C02]
 
 
NCT03954327: Combination Antiretroviral Therapy (cART) for PBC

Completed
2
37
Canada
Emtricitabine (FTC)/Tenofovir Disoproxil (TDF), Truvada, Raltegravir, Isentress, Placebo Oral Capsule [CEBOCAP], placebo
University of Alberta, Merck Sharp & Dohme LLC
Primary Biliary Cholangitis
10/22
01/24
NCT03174977: Pharmacokinetics Distribution of Raltegravir by PET/MR

Recruiting
1
10
US
18F-Raltegravir
University of California, San Francisco, Merck Sharp & Dohme LLC
HIV-1-infection
11/24
01/25

Download Options